Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03378414 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jun 30, 2026 to Jun 30, 2027
    • Start date: Dec 31, 2025 to Dec 31, 2026
    • Study completion date: Dec 31, 2026 to Dec 31, 2027
    v11
  2. Primary completion date: Dec 31, 2025 to Jun 30, 2026
    • Start date: Jun 30, 2025 to Dec 31, 2025
    v10
  3. Primary completion date: Jun 30, 2025 to Dec 31, 2025
    • Start date: Dec 31, 2024 to Jun 30, 2025
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    v9
  4. Primary completion date: Jun 2024 to Jun 30, 2025
    • Start date: Dec 2023 to Dec 31, 2024
    • Study completion date: Dec 2024 to Dec 31, 2025
    v8
  5. Primary completion date: Jun 2023 to Jun 2024
    • Start date: Dec 2022 to Dec 2023
    • Study completion date: Dec 2023 to Dec 2024
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Start date: Jun 2022 to Dec 2022
    • Primary completion date: Dec 2022 to Jun 2023
    v6
  2. Start date: Mar 2022 to Jun 2022
    • Primary completion date: Jun 2022 to Dec 2022
    • Study completion date: Dec 2022 to Dec 2023
    v5
  3. Start date: Feb 2022 to Mar 2022v4
  4. Start date: Oct 2021 to Feb 2022
    • Study title expanded, about 1 word
    v3
  5. Primary completion date: Jan 2019 to Jun 2022
    • Start date: Jan 2018 to Oct 2021
    • Study completion date: Dec 2019 to Dec 2022
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is verify the safety and efficacy of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Spinocerebellar Ataxia, and in addition, explore the possible mechanisms of UC-MSC therapy in Spinocerebellar Ataxia.
Trial Details
NCT Number NCT03378414
Lead Sponsor Sclnow Biotechnology Co., Ltd.
Conditions
(from sponsor)		 Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia Type 6
Related terms Machado-Joseph Disease, Spinocerebellar Ataxias
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov